(-0.14%) 5 461.60 points
(-0.34%) 38 980 points
(0.23%) 17 758 points
(0.37%) $81.13
(-3.48%) $2.66
(-0.93%) $2 309.20
(-0.30%) $28.78
(1.49%) $1 001.10
(0.27%) $0.936
(0.78%) $10.69
(0.38%) $0.791
(-0.47%) $87.08
Live Chart Being Loaded With Signals
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...
Stats | |
---|---|
本日の出来高 | 220 |
平均出来高 | 0 |
時価総額 | 322.78M |
EPS | $-1.030 ( Q1 | 2024-05-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0500 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Wiggans Thomas G | Buy | 10 000 | Voting Common Stock |
2023-11-21 | Wiggans Thomas G | Buy | 10 000 | Voting Common Stock |
2023-11-20 | Wiggans Thomas G | Buy | 10 000 | Voting Common Stock |
2023-11-17 | Wiggans Thomas G | Buy | 10 000 | Voting Common Stock |
2023-11-16 | Wiggans Thomas G | Buy | 10 000 | Voting Common Stock |
INSIDER POWER |
---|
90.52 |
Last 82 transactions |
Buy: 29 502 185 | Sell: 1 800 772 |
Jasper Therapeutics, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Jasper Therapeutics, Inc. 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-1.11M (0.00 %) |
EPS: | $-6.18 |
FY | 2023 |
収益: | $0 |
総利益: | $-1.11M (0.00 %) |
EPS: | $-6.18 |
FY | 2022 |
収益: | $0 |
総利益: | $-1.31M (0.00 %) |
EPS: | $-6.63 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company\'s lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。